Role of alpha-fetoprotein in the diagnosis and management of hepatocellular carcinoma

Journal of Gastroenterology and Hepatology (Australia)

Volumn 14, Issue SUPPL., 1999, Pages

  Johnson, Philip J ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Alpha fetoprotein; Hepatocellular carcinoma; Tumour markers

Indexed keywords

ALPHA FETOPROTEIN; DOXORUBICIN; FLUOROURACIL; INTERFERON; PLATINUM;

ARTICLE; BLOOD LEVEL; CHEMICAL STRUCTURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; DOSE RESPONSE; GENE THERAPY; LIVER CELL CARCINOMA; PATIENT MONITORING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0033020416     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.1999.01873.x     Document Type: Article

References (33)

1. Bergstrand CG, Czar D. Demonstration of a new protein fraction in serum from the human fetus. Scand. J. Clin. Lab. Invest. 1956; 8: 174.
2. Abelev GI, Perova SD, Khramkova NI et al. Production of embryonal alphafetoprotein by transplantable mouse hepatomas. Biochimia USSR 1963; 36: 625-34.
3. Tatarinov YS. Detection of embryospecific alpha-globulin in the blood sera of patients with primary liver tumour. Vopr. Med. Khim. 1964; 10: 90-1.
4. Gitlin D, Boesman M. Sites of serum alpha-fetoprotein synthesis in the human and in the rat. J. Clin. Invest. 1967; 46: 1010-16.
5. Chayvialle JAP, Ganguli PC. Radioimmunoassay of alpha-fetoprotein in human plasma. Lancet 1973; i: 1355-7.
6. Hirai H, Nishi S, Watabe H. Radioimmunoassay of alpha-fetoprotein. Protides of the Biological Fluids. 1972; 20: 579-87.
7. Heyward WL, Lanier AP, Bener TR et al. Early detection of primary hepatocellular carcinoma by screening for alpha-fetoprotein in high-risk families. Lancet 1983; ii: 1161-2.
8. McIntire KR, Waldmann TA, Moertal CG, Go VLW. Serum alpha fetoprotein in patients with neoplasms of the gastrointestinal tract. Cancer Res. 1975; 35: 991-6.
9. Bernades P, Smadja M, Rueff B et al. Presence de l'Alpha-foetoproteine serique dans quatre cas de cancers. Digestifs autres que l'Hepatome. Presse Med. 1971; 79: 1585-7.
10. Bloomer JR, Waldmann TA, McIntire KR, Klatskin G. Serum alpha fetoprotein levels in patients with non-neoplastic liver diseases. Gastroenterology 1973; 65: 530.
11. Johnson PJ, Portmann B, Williams R. Alpha-fetoprotein concentration measured by radioimmunoassay in the diagnosing and excluding of hepatocellular carcinoma. Br. Med. J. 1978; 2: 661-3.
12. Johnson PJ, Williams R. Serum alpha-fetoprotein estimations and doubling time in hepatocellular carcinoma: Influence of therapy and possible value in early detection. J. Natl Cancer Inst. 1980; 64: 1329-32.
13. Yoshima H, Mizuochi T, Ishii M, Kobata A. Structure of the asparagine-linked sugar chains of alpha-fetoprotein purified from human ascites fluid. Cancer Res. 1980; 40: 4276-81.
14. Pucci P, Siciliano R, Malorni A et al. Human alpha-fetoprotein primary structure: A mass spectrometric study. Biochemistry 1991; 30: 5061-6.
15. Yamashita K, Taketa K, Nishi S, Fukushima K, Ohkura T. Sugar chains of human cord serum alphafetoprotein: Characteristics of N-linked sugar chains of glycoproreins produced in human liver and hepatoccllular carcinomas. Cancer Res. 1993; 53: 2970-5.
16. Shimizu K, Taniichi T, Satomura S, Matsuura S, Taga H, Taketa K. Establishment of assay kits for determination of microheterogeneitics of alpha-fetoprotein using lectin-affinity electrophoresis. Clin. Chim. Acta 1993; 214: 3-12.
17. Taketa K, Endo Y, Sekiya C et al. A collaborative study for the evaluation of lectin-reactive alpha-fetoproteins in early detection of hepatocellular carcinoma. Cancer Res. 1993; 53: 5419-23.
18. Sato Y, Nakata K, Kato Y et al. Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein. N. Engl. J. Med. 1993; 328: 1802-6.
19. Shiraki K, Takase K, Tameda Y, Hamada M, Kosaka Y, Nakano T. A clinical study of lectin-reactive alpha-fetoprotein as an early indicator of hepatocellular carcinoma in the follow-up of cirrhotic patients. Hepatology 1995; 22: 802-7.
20. Burditt L, Johnson M, Johnson PJ, Williams R. Detection of hepatocellular carcinoma-specific alpha fetoprotein by isoelectric focusing. Cancer 1994; 74: 25-9.
21. Johnson PJ, Ho S, Cheng P, Chan A, Leung T, Yuen J. Germ cell tumours express a specific alpha-fetoprotein variant detectable by isoelectric focusing. Cancer 1995; 75: 1663-8.
22. Johnson PJ, Leung N, Cheng P et al. 'Hepatoma-specific' alphafetoprotein may permit preclinical diagnosis of malignant change in patients with chronic liver disease. Br. J. Cancer 1997; 75: 236-40.
23. 90yttrium microspheres. Int. J. Radiat. Oncol. Biol. Phys. 1998; 40: 583-92.
24. Leung WT, Patt YZ, Mok TSK et al. Phase II study of cisplatin, doxorubicin, 5-fluorouracil and alpha-interferon for advanced hepatocellular carcinoma. Proc. ASCO 1998; 17: 267.
25. Matsumura M, Niwa Y, Kato N et al. Detection of α-fetoprotein mRNA, an indicator of hematogenous spreading hepatocellular carcinoma, in the circulation: Possible predictor of metastatic hepatocellular carcinoma. Hepatology 1994; 20: 1418-25.
26. Komeda T, Fukuda Y, Sando T et al. Sensitive detection of circulating hepatocellular carcinoma cells in peripheral venous blood. Cancer 1995; 75: 2214-19.
27. Matsumura M, Niwa Y, Hikiba Y. Sensitive assay for detection of hepatocellular carcinoma associated gene transcription (alpha fetoprotein mRNA) in blood. Biochem. Biophys. Res. Commun. 1995; 207: 813-18.
28. Wong IHN, Johnson PJ. Semi-quantification of circulating hepatocellular carcinoma cells through mRNA markers for predicting metastasis. Br. J. Cancer 1997; 76: 628-33.
29. Chelly J, Concordet JP, Kaplan JC, Kalm A. Illegitimate transcription: Transcription of any gene in any cell type. Proc. Natl Acad. Sci. USA 1989; 86: 2617-21.
30. Xu GW, Sun ZT, Forrester K. Growth inhibition of hepatocellular carcinoma in vitro by tissue-specific expression of the p53 tumor suppressor gene. Proc. Ann. AACR 1994; 35: A3593.
31. Kanai F, Lan KH, Shiratori Y et al. In vivo gene therapy for alphafetoprotein producing hepatocellular carcinoma by adenovirus-mediated transfer of cytosine deaminase gene. Cancer Res. 1997; 57: 461-5.
32. Qian C, Bilbao R, Bruna O et al. Induction of sensitivity to gancyclovir in human hepatocellular carcinoma cells by adenovirus-mediated gene transfer of herpes simplex virus thymidine kinase. Hepatology 1995; 22: 118-23.
33. Wills KN, Huang WM, Harris MP et al. Gene therapy for hepatocellular carcinoma: Chemosensitivity conferred by adenovirus-mediated transfer of the HSV-I thymidine kinase gene. Cancer Gene Ther. 1995; 2: 191-7.